Alfred Hess, MD
Orthopaedic Surgery · Temple Terrace, FLNPI 1578568291
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), consulting fees and education — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Extremity Medical at 33.2% of the total. Reporting peaked in 2023 at $7,202 and has fallen 78.4% since, to $1,553 in 2025.
Across 131 payments — averaging $132.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Extremity Medical$6K
- MVP Orthopedics Inc$2K
- Trimed, Inc.$2K
- Axogen$1K
- Stryker$1K
- Polynovo North America LLC$932
- plus $4K from 25 others
Across 6 payments — averaging $722.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$4K
What the payments were for
- Consulting fees$5,75033%
- Travel & lodging$1,0036%
- Food & beverage$8,46349%
- Education$2,09912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Extremity Medical | 1 | $5,750 |
| MVP Orthopedics Inc | 5 | $2,257 |
| Trimed, Inc. | 5 | $1,987 |
| Axogen | 14 | $1,259 |
| Stryker | 29 | $1,179 |
| Polynovo North America LLC | 11 | $932 |
| Coastal Medical Technologies LLC | 14 | $755 |
| Endo Pharmaceuticals Inc. | 10 | $395 |
| Acumed LLC | 5 | $362 |
| Anika Therapeutics, Inc. | 3 | $260 |
| Alafair Biosciences, Inc. | 1 | $238 |
| My01 Inc. | 1 | $195 |
| Sanara Medtech Inc. | 1 | $163 |
| Medartis Inc. | 1 | $149 |
| Sonex Health, Inc. | 1 | $137 |
| Smith+Nephew | 4 | $134 |
| Kerecis Limited | 1 | $132 |
| Biocomposites Inc | 1 | $132 |
| Orthofix Medical, Inc. | 1 | $131 |
| Innovation Technologies Inc | 1 | $113 |
| Amgen(2 entities) | 6 | $111 |
| Exsomed Corporation | 1 | $97 |
| Checkpoint Surgical, Inc | 1 | $88 |
| Endo USA, Inc. | 3 | $77 |
| Avita Medical Americas, LLC | 1 | $73 |
| Illuminoss Medical, Inc. | 1 | $51 |
| ERMI LLC | 2 | $47 |
| Bioventus LLC | 3 | $43 |
| Linvatec Corporation | 1 | $33 |
| Biocircuit Technologies Inc | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KinematX$5,750
- Novosorb BTM$649
- AVANCE NERVE GRAFT$576
- Kerecis Omega3 Marigen$529
- ACUMED$525
- VARIAX$321
- Physio-Stim$261
- AxoGuard Nerve Connector$252
- AxoGuard Nerve Protector$252
- VersaWrap$238
- MY01 Continuous Compartmental Pressure Monitor$195
- TACTOSET$193
- BIO4$163
- REUNION$163
- CellerateRx$163
- APTUS$149
- ULTRAGUIDECTR$137
- ULTRAGUIDETFR$137
- Kerecis Omega3 SurgiClose$132
- Stimulan$132
How this compares
$17,315 in reported general payments places this provider in the 70th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiaflexCollagenase Clostridium Hist. | 11 | $93,099 |
| Ibuprofen | 17 | $162 |
| Methylprednisolone | 16 | $124 |
| Meloxicam | 48 | $102 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Endo Pharmaceuticals Inc.Xiaflex | $395 | $93,09911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,263 orthopaedic surgery providers in Florida.
Other orthopaedic surgery in Temple Terrace
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- Thomas BernasekTemple Terrace$6.4M
- Kenneth GustkeTemple Terrace$5.2M
- Mark MighellTemple Terrace$4.3M
- Michael GarciaTemple Terrace$1.1M
- Christopher BakerTemple Terrace$575K
- John SmallTemple Terrace$467K
- Brian PalumboTemple Terrace$414K
- Andrew CooperClearwater$102M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.